These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10917674)

  • 1. Role of matrix metalloproteinases in normal and disease processes.
    McDonnell S; Morgan M; Lynch C
    Biochem Soc Trans; 1999 Aug; 27(4):734-40. PubMed ID: 10917674
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metalloproteinases. Structure and function].
    Lipka D; Boratyński J
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():328-36. PubMed ID: 18614970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases.
    Zitka O; Kukacka J; Krizkova S; Huska D; Adam V; Masarik M; Prusa R; Kizek R
    Curr Med Chem; 2010; 17(31):3751-68. PubMed ID: 20846107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in matrix metalloproteinase research.
    Murphy G; Nagase H
    Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metalloproteinases and their inhibitors: the importance of extracellular matrix degradation in malignancy].
    Sela B
    Harefuah; 2000 Dec; 139(11-12):446-51. PubMed ID: 11341192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J
    Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases in repair.
    Parks WC
    Wound Repair Regen; 1999; 7(6):423-32. PubMed ID: 10633001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The source of matrix-degrading enzymes in human cancer: Problems of research reproducibility and possible solutions.
    Madsen DH; Bugge TH
    J Cell Biol; 2015 Apr; 209(2):195-8. PubMed ID: 25918222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis].
    Yoshihara Y; Yamada H
    Clin Calcium; 2007 Apr; 17(4):500-8. PubMed ID: 17404478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix turnover.
    Kerrigan JJ; Mansell JP; Sandy JR
    J Orthod; 2000 Sep; 27(3):227-33. PubMed ID: 11099555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snapshots of the reaction mechanism of matrix metalloproteinases.
    Bertini I; Calderone V; Fragai M; Luchinat C; Maletta M; Yeo KJ
    Angew Chem Int Ed Engl; 2006 Dec; 45(47):7952-5. PubMed ID: 17096442
    [No Abstract]   [Full Text] [Related]  

  • 13. Elastinolytic matrix metalloproteinases and their inhibitors as therapeutic targets in atherosclerotic plaque instability.
    Smeglin A; Frishman WH
    Cardiol Rev; 2004; 12(3):141-50. PubMed ID: 15078583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of matrix metalloproteinases in patients with malignant tumors].
    Stanciūte D; Didziapetriene J; Kadziauskas J
    Medicina (Kaunas); 2004; 40(12):1143-50. PubMed ID: 15630339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro.
    Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A
    Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human matrix metalloproteinases: characteristics and pathologic role in altering mesangial homeostasis.
    Keeling J; Herrera GA
    Microsc Res Tech; 2008 May; 71(5):371-9. PubMed ID: 18300288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies.
    Hemmann S; Graf J; Roderfeld M; Roeb E
    J Hepatol; 2007 May; 46(5):955-75. PubMed ID: 17383048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unifying role of matrix metalloproteinases in atheroma and vascular stroke.
    Tayebjee MH; Lip GY; MacFadyen RJ
    Stroke; 2004 Oct; 35(10):2239. PubMed ID: 15308790
    [No Abstract]   [Full Text] [Related]  

  • 20. Multilevel regulation of matrix metalloproteinases in tissue homeostasis indicates their molecular specificity in vivo.
    Gaffney J; Solomonov I; Zehorai E; Sagi I
    Matrix Biol; 2015; 44-46():191-9. PubMed ID: 25622911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.